Sunways Rohto Pharmaceutical Private Limited, a active private limited company, was established on 22 May 1986 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1986PTC008689. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹3.25 M.
Formerly known as Deep Care Health Private Limited. It upholds a compliant status. Employing 87 professional, Its leadership includes Anil Kumar Jagirdar (Nominee Director), Daiki Kato (Additional Director), Anupam Kantilal Shroff (Director). Past directors included Sumit Gupta, Aatish Anupam Shroff, Lekh Raj Juneja. It holds ₹40.52 Cr open charges and ₹4.28 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 804, Gidc Dholka,, Ahmedabad, Gujarat, 387810.
U24231GJ1986PTC008689
008689
22 May 1986
₹6.00 M
₹3.25 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Sunways Rohto Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Kumar Jagirdar | Nominee Director | 30 Sep 2024 | Current |
| Daiki Kato | Additional Director | 15 Jul 2020 | Current |
| Anupam Kantilal Shroff | Director | 16 Oct 2017 | Current |
| Bhadresh Kantilal Shroff | Managing Director | 20 Mar 1992 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 04 Sep 2024 | Past |
| Pramod Abcsdd | Director | 16 Mar 2023 | Past |
| Pramod Abcsdd | Director | 24 Jun 2020 | Past |
| Pramod Abcsdd | Director | 29 Oct 2013 | Past |
| Pramod Abcsdd | Director | 29 Oct 2013 | Past |
| Pramod Abcsdd | Director | 31 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sunways Rohto Pharmaceutical Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.18% decrease. The company also saw a substantial improvement in profitability, with a 41.94% increase in profit. The company's net worth moved up by a moderate rise of 3.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sunways Rohto Pharmaceutical had a public holding of 24.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹405,200,000.00
₹42,836,524.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2023 | Hdfc Bank Limited | ₹40.50 Cr | Open |
| 26 Apr 1988 | Bank Of India | ₹0.20 M | Open |
| 15 Mar 2022 | Others | ₹1.00 Cr | Satisfied |
| 04 Mar 2022 | Others | ₹3.00 Cr | Satisfied |
| 16 May 1989 | Peoples Co- Op. Bank Ltd. | ₹0.09 M | Satisfied |
Explore comprehensive loan charge details -
Sunways Rohto Pharmaceutical has a workforce of 87 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sunways Rohto Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunways Rohto Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sunways Rohto Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Anil Kumar Jagirdar was appointed as a Nominee Director was appointed as a Nominee Director on 30 Sep 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
The activity Sunways Rohto Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
Progress on A charge registered on 04 Mar 2022 via Charge ID 100574660 with Others was fully satisfied on 22 Sep 2023. was documented.
The activity A charge with Hdfc Bank Limited of Rs. 405.00 M registered on 30 May 2023 with Charge ID 100734411 was modified on 02 Aug 2023. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 405.00 M with Charge ID 100734411 was registered on 30 May 2023. was documented.
The CIN of Sunways Rohto Pharmaceutical Private Limited is U24231GJ1986PTC008689.
Sunways Rohto Pharmaceutical Private Limited is headquartered at 804, Gidc Dholka,, Ahmedabad, Gujarat, 387810.
Sunways Rohto Pharmaceutical Private Limited was incorporated on 22 May 1986.
The current directors of Sunways Rohto Pharmaceutical Private Limited are
The primary industry of Sunways Rohto Pharmaceutical Private Limited is Manufacturing.
Sunways Rohto Pharmaceutical Private Limited is unlisted.
The authorized capital of Sunways Rohto Pharmaceutical Private Limited is ₹6.00 M, and the paid-up capital is ₹3.25 M.
The compliance status of Sunways Rohto Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX